Section 6.3, para 5, lines 15-17 which previously read:
Section 6.3, para 5, lines 15-17 which previously read:
The mean percent changes in LDL-C, TG and apo B levels from baseline were -21, -14 and -23%, respectively, in the rhSA-treated group.
Should read:
The mean percent changes in LDL-C, TG and apo B levels compared with placebo were -21, -14 and -23%, respectively, in the rhSA-treated group. Section 6.3, para 6, lines 1-3 which previously read: Adverse events were mild and similar in the treated and placebo groups, and included headache (10%), pyrexia (7%), diarrhea (6%), runny nose (4%) and nausea (3%).
Adverse events were mild and similar in the treated and placebo groups, and included headache (n = 10), pyrexia (n = 7), diarrhea (n = 6), runny nose (n = 4) and nausea (n = 3). 
